drugset / Trial / NCT02645370

Efficacy and Safety of Danzhen

NCT02645370

Non-randomizedParallel-groupOpen-labelPrevention

Summary

The purpose is to evaluate the effectiveness and safety profile of Danzhen for the prophylaxis of migraine in a "real-world" setting.

Timeline

Start
2016-02
Primary completion
2017-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Danzhen Unknown 3 unknown
Comparator Topiramate Small molecule 150 mg

Indications